Spots Global Cancer Trial Database for A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199
Official Title: A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199
Study ID: NCT01969669
Conditions
Study Description
Brief Summary: This is an open-label multicenter, study to assess the pharmacokinetic interaction of ketoconazole with ABT-199 in up to 12 subjects with relapsed or refractory non-Hodgkin's lymphoma.
Detailed Description: This is a Phase 1 study designed to assess how the body processes the study drug ABT-199 when taken alone and in combination with ketoconazole and to assess the safety of ABT-199 in combination with ketoconazole. Subjects may enroll in a separate extension study to continue receiving ABT-199 after completion of this study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Site Reference ID/Investigator# 97498, Tucson, Arizona, United States
Site Reference ID/Investigator# 92593, Lebanon, New Hampshire, United States
Site Reference ID/Investigator# 101415, Hackensack, New Jersey, United States
Contact Details
Name: David Chien, MD
Affiliation: AbbVie
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
